Fluorescence News and Research

RSS

European researchers take lid off the genome

European researchers have made significant progress unravelling how genes are governed and why this sometimes goes wrong in disease.

15 Jun 2008

Targeted quantum rods probe blood-brain barrier

One of the chief difficulties in treating brain tumors involves getting potential tumor-killing drugs across the blood-brain barrier and into the brain.

15 Jun 2008

Coated gold nanoparticles for drug delivery

In work that could at the same time impact the delivery of drugs and explain a biological mystery, MIT engineers have created the first synthetic nanoparticles that can penetrate a cell without poking a hole in its protective membrane and killing it.

11 Jun 2008

New cheaper method for mapping disease genes

Scientists at the Swedish medical university Karolinska Institutet have developed a new DNA-sequencing method that is much cheaper than those currently in use in laboratories. They hope that this new method will make it possible to map disease genes in large patient groups, which in turn can mean quicker breakthroughs for new treatments for a wide variety of diseases.

26 May 2008

Fluorescent 'barcodes' called nanostrings could revolutionise diagnostics

A new technology with research and clinical application including the early detection of disease has been invented and developed by University of Queensland researchers.

From NanoString Technologies 22 May 2008

Yerkes researchers develop first transgenic nonhuman primate model of Huntington's disease

In the first study of its kind, researchers at the Yerkes National Primate Research Center, Emory University, in collaboration with researchers from the Department of Human Genetics at Emory's School of Medicine, have developed the first transgenic nonhuman primate model of Huntington's disease (HD), one of the most devastating human neurodegenerative diseases.

22 May 2008

NCI scientists visualize gene regulation in living cells

A research team led by scientists at the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), has applied advanced imaging methods and computer simulations to be able to glance at the regulation of a cancer-related gene in a living cell. They found that the efficiency with which the components of the cell's gene reading machinery come together has an impact on gene expression, the process by which a gene translates its information into a new protein. The findings, published in the May 23, 2008 issue of Molecular Cell, shed new light on the means by which living cells regulate gene activity.

22 May 2008

High resolution confocal endomicroscopy probe system tells whether colon polyp is benign without removal

A probe so sensitive that it can tell whether or not a cell living within the human body is veering towards cancer development may revolutionize how future colonoscopies are done, say researchers from the Mayo Clinic in Jacksonville, Fla.

21 May 2008

Scripps Research Institute awarded patent for revolutionary technology

The Scripps Research Institute has been awarded U.S. Patent No. US 7,375,234 B2, which covers a broad class of chemical reactions that mimic biological efficiency and opens the door to a new world of chemistry.

20 May 2008

Dendrimers improve imaging with magnetic nanoparticles

Dendrimers are spherical polymer nanoparticles that have shown promise as targeted anticancer drug delivery vehicles. Iron oxide nanoparticles have already demonstrated the ability to image tumors and metastatic lesions.

20 May 2008

Multifunctional nanoparticles image, target, and treat tumors

Encapsulating magnetic iron oxide nanoparticles within a silica shell has yielded a new multifunctional nanoparticle that has the potential to image, target, and treat tumors with water-insoluble anticancer drugs. A report of this work appears in the journal ACS Nano.

20 May 2008

Chip-based device measures drug resistance in tumor cells

Multiple drug resistance is a major cause of anticancer therapy failure. Most drug-resistance cancer cells develop this unfortunate characteristic due to a drug-pumping protein known as P-glycoprotein.

20 May 2008

First evidence of native dendritic cells in brain

In a finding that has the potential to change the way researchers think about the brain, scientists at Rockefeller University have found dendritic cells where they've never been seen before: among this organ's neurons and connective cells.

15 May 2008

Simple, painless hair test detects breast cancer

A test developed by Australian scientists which promises to be able to pick up breast cancer from a hair sample, could be commercially available later this year.

13 May 2008

Researchers launch lung cancer screening trial

Scientists are testing a new way of detecting lung cancer at an early stage in people at greatest risk of developing the disease.

9 May 2008

Research reveals workings of anti-HIV drugs

Using ingenious molecular espionage, scientists have found how a single key enzyme, seemingly the Swiss Army knife in HIV's toolbox, differentiates and dynamically binds both DNA and RNA as part of the virus's fierce attack on host cells. The work is described this week (May 7) in the journal Nature.

8 May 2008

Scientists discover how reverse transcriptase molecules interact with the HIV genome

Using ingenious molecular espionage, scientists have found how a single key enzyme, seemingly the Swiss army knife in HIV's toolbox, differentiates and dynamically binds both DNA and RNA as part of the virus' fierce attack on host cells. The work is described this week in the journal Nature.

7 May 2008

Clockwork PCR including sample prep

Analysis and diagnosis in a chip format are coming of age, but their practical application has been limited because until now, the sample usually had to be prepared separately and on a nonminiaturized scale.

6 May 2008

Chronic inflammation triggers cell fusions that could protect neurons

Chronic inflammation triggers bone marrow-derived blood cells to travel to the brain and fuse with a certain type of neuron up to 100 times more frequently than previously believed, according to a new study from the Stanford University School of Medicine.

20 Apr 2008

Quantum rods light up pancreatic cancer cells

Quantum dots have shown promise as ultrabright contrast agents for use in a variety of cancer imaging studies. Now, a team of investigators at the Multifunctional Nanoparticles in Diagnosis and Therapy of Pancreatic Cancer Platform Partnership, headed by Paras Prasad, Ph.D., of the State University of New York at Buffalo, has shown that quantum rods may perform even better than their spherical cousins.

18 Apr 2008